Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Research Council grant · Running

ADIPOhealth Deciphering the role of adipose tissue in cardiac health and disease: ADIPOhealth

Coordinator
Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos Iii, Spain
Runs
1 April 2026 to 31 March 2032
Status
Running
EU funding
€10.2m
Total cost
€10.2m
Partners
5 organisations in 4 countries
Type
European Research Council grant
Grant agreement
101224726

What the project is doing

In the project's own words, from its summary on CORDIS.

Obesity is a major risk factor for cardiovascular diseases (CVD), primarily due to its disruption of heart metabolism and the alteration of crucial signaling pathways involved in maintaining cardiac function, including those regulating energy homeostasis, myocardial contractility, and stress response. Nevertheless, the underlying mechanisms for these effects remain poorly understood. Obesity leads to changes in the secretion, by adipose tissue (AT), of metabokines—proteins, peptides, metabolites, and extracellular vesicles (EVs)—that are critical for inter-organ communication and significantly affect heart function.

AT is a key endocrine organ involved in whole-body homeostasis, yet its impact on cardiac health is still not fully understood. We hypothesize that AT dysfunction is a key driver of heart disease through disrupted metabokine secretion. Our preliminary findings suggest that specific AT alterations profoundly affect heart metabolism and function. ADIPOhealth aims to advance our understanding of how AT controls cardiac function through the following objectives:1.Identify novel metabokines (adipokines, metabolites, microproteins, microRNAs, and EVs) secreted by AT that contribute to the development of heart disease.2.Discover novel metabokines that regulate cardiomyocyte metabolism using cellular models.3.Investigate, in mouse models of AT-specific dysfunction, how cardiac function may be influenced by changes in metabokines.4.Functionally characterize these metabokines in cell culture, mouse models, and human samples.5.Develop therapeutic strategies targeting AT dysfunction and metabokine-induced cardiac damage.

By integrating multi-omics data from human and mouse studies, we aim to elucidate the molecular mechanisms by which AT influences heart health. Our results not only will deepen our understanding of metabolic crosstalk between organs but will also identify new therapeutic targets to combat cardiometabolic diseases (CMDs).

Who is involved

OrganisationCityCountryRole
Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos IiiMadridSpainCoordinator
Kobenhavns UniversitetKobenhavnDenmarkParticipant
King's College LondonLondonUnited KingdomParticipant
The Regents of the University of CaliforniaOaklandUnited StatesParticipant
The University of IowaIowa CityUnited StatesParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI